Crestline Management, LP Ardelyx, Inc. Transaction History

Crestline Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.8 $1.11 Million - $1.74 Million	-299,750 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$5.05 - $7.9 $815,130 - $1.28 Million	-161,412 Reduced 35.0%	299,750 $1.51 Million
Q4 2017 Feb 14, 2018	BUY	$4.85 - $7.8 $1.55 Million - $2.5 Million	320,096 Added 226.91%	461,162 $3.04 Million
Q3 2017 Nov 14, 2017	SELL	$4.35 - $5.7 $307,375 - $402,767	-70,661 Reduced 33.37%	141,066 $790,000
Q2 2017 Aug 14, 2017	BUY	N/A	211,727	211,727 $1.08 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.